2.44
price down icon14.08%   -0.40
after-market Dopo l'orario di chiusura: 2.41 -0.03 -1.23%
loading

Cns Pharmaceuticals Inc Azioni (CNSP) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
35.03%
3.2534
2.4094 4.3377 3.20 5.6289
Operating Income/Loss
35.03%
-3.2534
-2.4094 -4.3377 -3.20 -5.6289
Nonoperating Income/Loss
1.40%
0.0349
0.0344 0.0363 0.0237 0.023
Income/Loss From Continuing Operations Before Tax
35.52%
-3.2185
-2.375 -4.3013 -3.1764 -5.6059
Income/Loss From Continuing Operations After Tax
35.52%
-3.2185
-2.375 -4.3013 -3.1764 -5.6059
Net Income/Loss
35.52%
-3.2185
-2.375 -4.3013 -3.1764 -5.6059
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
50.99%
0.5589
0.3701 2.7266 -7.1991 22.18
Diluted Average Shares
50.99%
0.5589
0.3701 2.7266 -7.1991 22.18
Basic Earnings Per Share
10.28%
-5.76
-6.42 -1.58 -37.33 -0.25
Diluted Earnings Per Share
10.28%
-5.76
-6.42 -1.58 -37.33 -0.25
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):